Austar Lifesciences Limited (6118.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 400.55M |
| Enterprise Value | 467.78M |
| P/E Ratio | 18.77 |
| PEG Ratio | -0.37 |
| Price/Sales Ratio | 0.2 |
| Price/Book Ratio | 0.39 |
| Enterprise/Revenue | 0.27 |
| Enterprise/EBITDA | 6.25 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.01 |
| Operating Margin | 0.02 |
AD
Management Effectiveness
| Return On Assets | 0.01 |
| Return On Equity | 0.02 |
Income Statement
| Revenue | 1.53B |
| Revenue/Share | 3.13 |
| Gross Profit | 293.27M |
| EBITDA | 73.05M |
| Net Income | 33.81M |
| Diluted EPS | 0.07 |
Balance Sheet
| Total Cash | 255.32M |
| Total Cash/Share | 0.5 |
| Total Debt | 362.65M |
| Total Debt/Equity | 0.44 |
| Current Ratio | 1.36 |
| Book Value Per Share | 1.63 |
Price History
| 52-Week Change | -38.75 |
| 52-Week High | 1.6 |
| 52-Week Low | 0.65 |
| Moving Average 50 Days | 0.71 |
| Moving Average 200 Days | 0.8 |
Statistics
| Average Volume | 45,015 |
| Shares Outstanding | 512.58M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
